Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Shire CEO's buyout plans thwarted when AbbVie came calling
Fierce Pharma
Monday, June 30, 2014 - 5:59pm
tags:
Shire, AbbVie, Flemming Ornskov
Bluebird Bio acquires Precision Genome Engineering
The Fly on the Wall
Monday, June 30, 2014 - 5:58pm
tags:
Bluebird Bio, M&A, Precision Genome Engineering
Why Teva's Magic Bullet Could Misfire
Motley Fool
Monday, June 30, 2014 - 5:57pm
tags:
Teva Pharmaceuticals, Copaxone, MS, multiple sclerosis
Biogen Hemophilia Drugs Launch Into The Unknown
Investors.com
Monday, June 30, 2014 - 5:53pm
tags:
Biogen Idec, hemophilia, Alprolix, Eloctate
MannKind's Afrezza Approved but Will Doctors Prescribe It?
Motley Fool
Monday, June 30, 2014 - 5:45pm
tags:
MannKind, Afrezza, insulin, diabetes, inhaled insulin
1 Critical Question Swirling Around Medtronic's Mega-Merger
Motley Fool
Monday, June 30, 2014 - 5:44pm
tags:
M&A, Covidien, devices, Medtronic
Gilead Seeks Japanese Approval for Sovaldi
Yahoo/Zacks.com
Monday, June 30, 2014 - 5:43pm
tags:
Japan, hepatitis C, Sovaldi, Gilead Sciences
Supreme Court Says Small, Private Companies Don't Have To Provide Contraception
Yahoo/Business Insider
Monday, June 30, 2014 - 11:58am
tags:
Supreme Court, healthcare reform, insurance, contraceptives
GW Pharma rises after analyst sees promise in marijuana-derived epilepsy drug
The Fly on the Wall
Monday, June 30, 2014 - 11:56am
tags:
GW Pharma, epilpesy, marijuana, Epidiolex
Biotech vets sign up to launch Cidara with $32M, new drugs for fungal infections
Fierce Biotech
Monday, June 30, 2014 - 11:22am
tags:
Cidara, fungal infections
Stryker buys joint device maker Small Bone Innovations for up to $375M
Yahoo/AP
Monday, June 30, 2014 - 11:09am
tags:
M&A, devices, Stryker, Small Bone Innovations
UCB's Vimpat Positive for Partial-Onset Seizures
Yahoo/Zacks.com
Monday, June 30, 2014 - 11:07am
tags:
UCB Pharmaceuticals, partial seizures, Vimpat
MannKind’s Afrezza: Too Niche?
Barron's
Monday, June 30, 2014 - 11:06am
tags:
MannKind, Afrezza, diabetes, insulin, inhaled insulin
Geron Set To Explode As FDA Releases Partial Clinical Hold On Imetelstat Myelofibrosis Trial
Seeking Alpha
Monday, June 30, 2014 - 11:05am
tags:
Geron Set To Explode As FDA Releases Partial Clinical Hold On Imetelstat Myelofibrosis Trial
Seeking Alpha
Monday, June 30, 2014 - 11:05am
tags:
FDA, imetelstat, Geron, myelofibrosis
Afrezza Approval Opens The Door To Multi-Billion Dollar Markets For MannKind
Seeking Alpha
Monday, June 30, 2014 - 10:07am
tags:
FDA, inhaled insulin, insulin, Afrezza, MannKind, diabetes
Here's Everything We Know About The GlaxoSmithKline Sex Tape And The Chinese Bribery Allegations
Yahoo/Business Insider
Monday, June 30, 2014 - 9:41am
tags:
GSK, bribery, China
Merck nausea drug works in children in late-stage trial
Yahoo/Reuters
Monday, June 30, 2014 - 9:40am
tags:
Merck, chemotherapy-induced nausea and vomiting, Emend
Allergan says U.S. FDA sent 2nd letter on acute migraine treatment
Yahoo/Reuters
Monday, June 30, 2014 - 8:55am
tags:
FDA, Allergan, migraines, Semprana, Levadex, Valeant Pharmaceuticals
Tides turn for orthopedic firms; industry dynamics are shifting in the wake of Zimmer's Biomet acquisition
Morningstar
Monday, June 30, 2014 - 8:52am
tags:
Orthopedics, Zimmer, Biomet, M&A, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.